Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2000-7-31
pubmed:abstractText
To analyze clinical features, treatment results, and prognostic factors of primary central nervous system lymphoma (PCNSL) in Japan, we conducted a nationwide survey.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0360-3016
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
44
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
265-72
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10760418-Adolescent, pubmed-meshheading:10760418-Adult, pubmed-meshheading:10760418-Aged, pubmed-meshheading:10760418-Aged, 80 and over, pubmed-meshheading:10760418-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:10760418-Brain Neoplasms, pubmed-meshheading:10760418-Child, pubmed-meshheading:10760418-Child, Preschool, pubmed-meshheading:10760418-Combined Modality Therapy, pubmed-meshheading:10760418-Cyclophosphamide, pubmed-meshheading:10760418-Doxorubicin, pubmed-meshheading:10760418-Female, pubmed-meshheading:10760418-Health Care Surveys, pubmed-meshheading:10760418-Humans, pubmed-meshheading:10760418-Lymphoma, pubmed-meshheading:10760418-Male, pubmed-meshheading:10760418-Middle Aged, pubmed-meshheading:10760418-Multivariate Analysis, pubmed-meshheading:10760418-Prednisolone, pubmed-meshheading:10760418-Prednisone, pubmed-meshheading:10760418-Proportional Hazards Models, pubmed-meshheading:10760418-Radiotherapy Dosage, pubmed-meshheading:10760418-Recurrence, pubmed-meshheading:10760418-Retrospective Studies, pubmed-meshheading:10760418-Survival Rate, pubmed-meshheading:10760418-Vincristine
pubmed:year
1999
pubmed:articleTitle
Primary central nervous system lymphoma in Japan: a nationwide survey.
pubmed:affiliation
Department of Radiology, Kurume University School of Medicine, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study